nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—CYP1A2—Pentoxifylline—systemic scleroderma	0.132	0.254	CbGbCtD
Diphenhydramine—CYP1A2—Leflunomide—systemic scleroderma	0.126	0.242	CbGbCtD
Diphenhydramine—CYP2C9—Leflunomide—systemic scleroderma	0.114	0.218	CbGbCtD
Diphenhydramine—CYP2D6—Captopril—systemic scleroderma	0.0815	0.157	CbGbCtD
Diphenhydramine—CYP2C19—Prednisone—systemic scleroderma	0.0674	0.13	CbGbCtD
Diphenhydramine—CYP2C9—cardial valve—systemic scleroderma	0.026	0.378	CbGeAlD
Diphenhydramine—PTGS1—artery—systemic scleroderma	0.00356	0.0518	CbGeAlD
Diphenhydramine—CYP2C18—digestive system—systemic scleroderma	0.00341	0.0497	CbGeAlD
Diphenhydramine—PTGS1—endothelium—systemic scleroderma	0.00301	0.0438	CbGeAlD
Diphenhydramine—PTGS1—blood vessel—systemic scleroderma	0.00277	0.0404	CbGeAlD
Diphenhydramine—SLC22A2—digestive system—systemic scleroderma	0.00266	0.0388	CbGeAlD
Diphenhydramine—Dyspepsia—Pentoxifylline—systemic scleroderma	0.0019	0.00462	CcSEcCtD
Diphenhydramine—Vision blurred—Captopril—systemic scleroderma	0.00189	0.0046	CcSEcCtD
Diphenhydramine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00188	0.00458	CcSEcCtD
Diphenhydramine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00188	0.00456	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00186	0.00452	CcSEcCtD
Diphenhydramine—Constipation—Pentoxifylline—systemic scleroderma	0.00185	0.00449	CcSEcCtD
Diphenhydramine—Chills—Azathioprine—systemic scleroderma	0.0018	0.00439	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.00178	0.00433	CcSEcCtD
Diphenhydramine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00178	0.00433	CcSEcCtD
Diphenhydramine—Anorexia—Mometasone—systemic scleroderma	0.00177	0.00432	CcSEcCtD
Diphenhydramine—Palpitations—Captopril—systemic scleroderma	0.00177	0.00431	CcSEcCtD
Diphenhydramine—Urticaria—Pentoxifylline—systemic scleroderma	0.00171	0.00417	CcSEcCtD
Diphenhydramine—Chills—Leflunomide—systemic scleroderma	0.0017	0.00414	CcSEcCtD
Diphenhydramine—Agranulocytosis—Lisinopril—systemic scleroderma	0.00169	0.00412	CcSEcCtD
Diphenhydramine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00169	0.00411	CcSEcCtD
Diphenhydramine—Paraesthesia—Mometasone—systemic scleroderma	0.00167	0.00407	CcSEcCtD
Diphenhydramine—Dysuria—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00406	CcSEcCtD
Diphenhydramine—Dry mouth—Captopril—systemic scleroderma	0.00167	0.00406	CcSEcCtD
Diphenhydramine—Euphoric mood—Prednisone—systemic scleroderma	0.00166	0.00403	CcSEcCtD
Diphenhydramine—Confusional state—Captopril—systemic scleroderma	0.00165	0.00401	CcSEcCtD
Diphenhydramine—Pollakiuria—Mycophenolate mofetil—systemic scleroderma	0.00165	0.00401	CcSEcCtD
Diphenhydramine—Dyspepsia—Mometasone—systemic scleroderma	0.00164	0.00399	CcSEcCtD
Diphenhydramine—SLC22A5—skin of body—systemic scleroderma	0.00164	0.0238	CbGeAlD
Diphenhydramine—Chills—Mycophenolic acid—systemic scleroderma	0.00162	0.00395	CcSEcCtD
Diphenhydramine—Decreased appetite—Mometasone—systemic scleroderma	0.00162	0.00394	CcSEcCtD
Diphenhydramine—Fatigue—Mometasone—systemic scleroderma	0.00161	0.00391	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Captopril—systemic scleroderma	0.0016	0.0039	CcSEcCtD
Diphenhydramine—Tachycardia—Captopril—systemic scleroderma	0.0016	0.00388	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.00156	0.0038	CcSEcCtD
Diphenhydramine—Anorexia—Captopril—systemic scleroderma	0.00156	0.00379	CcSEcCtD
Diphenhydramine—Vision blurred—Leflunomide—systemic scleroderma	0.00156	0.00379	CcSEcCtD
Diphenhydramine—Asthenia—Pentoxifylline—systemic scleroderma	0.00155	0.00377	CcSEcCtD
Diphenhydramine—Tension—Mycophenolic acid—systemic scleroderma	0.00155	0.00376	CcSEcCtD
Diphenhydramine—HRH1—connective tissue—systemic scleroderma	0.00154	0.0224	CbGeAlD
Diphenhydramine—Nervousness—Mycophenolic acid—systemic scleroderma	0.00153	0.00372	CcSEcCtD
Diphenhydramine—Hypotension—Captopril—systemic scleroderma	0.00153	0.00372	CcSEcCtD
Diphenhydramine—Tinnitus—Lisinopril—systemic scleroderma	0.00152	0.0037	CcSEcCtD
Diphenhydramine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00148	0.00361	CcSEcCtD
Diphenhydramine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00361	CcSEcCtD
Diphenhydramine—Vertigo—Leflunomide—systemic scleroderma	0.00148	0.00361	CcSEcCtD
Diphenhydramine—Insomnia—Captopril—systemic scleroderma	0.00148	0.0036	CcSEcCtD
Diphenhydramine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00148	0.00359	CcSEcCtD
Diphenhydramine—Tremor—Mycophenolic acid—systemic scleroderma	0.00148	0.00359	CcSEcCtD
Diphenhydramine—Paraesthesia—Captopril—systemic scleroderma	0.00147	0.00357	CcSEcCtD
Diphenhydramine—Chills—Lisinopril—systemic scleroderma	0.00146	0.00356	CcSEcCtD
Diphenhydramine—Palpitations—Leflunomide—systemic scleroderma	0.00146	0.00355	CcSEcCtD
Diphenhydramine—Somnolence—Captopril—systemic scleroderma	0.00145	0.00354	CcSEcCtD
Diphenhydramine—CYP2C19—digestive system—systemic scleroderma	0.00145	0.0211	CbGeAlD
Diphenhydramine—Agitation—Mycophenolic acid—systemic scleroderma	0.00145	0.00352	CcSEcCtD
Diphenhydramine—Dyspepsia—Captopril—systemic scleroderma	0.00144	0.0035	CcSEcCtD
Diphenhydramine—Dizziness—Pentoxifylline—systemic scleroderma	0.00143	0.00347	CcSEcCtD
Diphenhydramine—PTGS1—connective tissue—systemic scleroderma	0.00142	0.0207	CbGeAlD
Diphenhydramine—Decreased appetite—Captopril—systemic scleroderma	0.00142	0.00346	CcSEcCtD
Diphenhydramine—CYP2B6—skin of body—systemic scleroderma	0.00142	0.0207	CbGeAlD
Diphenhydramine—Vertigo—Mycophenolic acid—systemic scleroderma	0.00142	0.00344	CcSEcCtD
Diphenhydramine—Fatigue—Captopril—systemic scleroderma	0.00141	0.00343	CcSEcCtD
Diphenhydramine—HRH1—smooth muscle tissue—systemic scleroderma	0.0014	0.0205	CbGeAlD
Diphenhydramine—Constipation—Captopril—systemic scleroderma	0.0014	0.0034	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.0014	0.0034	CcSEcCtD
Diphenhydramine—Tension—Lisinopril—systemic scleroderma	0.00139	0.00339	CcSEcCtD
Diphenhydramine—Palpitations—Mycophenolic acid—systemic scleroderma	0.00139	0.00339	CcSEcCtD
Diphenhydramine—Nervousness—Lisinopril—systemic scleroderma	0.00138	0.00335	CcSEcCtD
Diphenhydramine—Dry mouth—Leflunomide—systemic scleroderma	0.00137	0.00335	CcSEcCtD
Diphenhydramine—Vomiting—Pentoxifylline—systemic scleroderma	0.00137	0.00334	CcSEcCtD
Diphenhydramine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00136	0.00332	CcSEcCtD
Diphenhydramine—Rash—Pentoxifylline—systemic scleroderma	0.00136	0.00331	CcSEcCtD
Diphenhydramine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00136	0.00331	CcSEcCtD
Diphenhydramine—Headache—Pentoxifylline—systemic scleroderma	0.00135	0.00329	CcSEcCtD
Diphenhydramine—Feeling abnormal—Captopril—systemic scleroderma	0.00135	0.00328	CcSEcCtD
Diphenhydramine—Vision blurred—Lisinopril—systemic scleroderma	0.00134	0.00325	CcSEcCtD
Diphenhydramine—Asthenia—Mometasone—systemic scleroderma	0.00134	0.00325	CcSEcCtD
Diphenhydramine—Irritability—Prednisone—systemic scleroderma	0.00134	0.00325	CcSEcCtD
Diphenhydramine—Hypotension—Azathioprine—systemic scleroderma	0.00133	0.00325	CcSEcCtD
Diphenhydramine—Photosensitivity—Methotrexate—systemic scleroderma	0.00133	0.00324	CcSEcCtD
Diphenhydramine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00324	CcSEcCtD
Diphenhydramine—Tremor—Lisinopril—systemic scleroderma	0.00133	0.00324	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00132	0.00321	CcSEcCtD
Diphenhydramine—Tachycardia—Leflunomide—systemic scleroderma	0.00132	0.0032	CcSEcCtD
Diphenhydramine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00131	0.00319	CcSEcCtD
Diphenhydramine—SLC22A5—digestive system—systemic scleroderma	0.00131	0.019	CbGeAlD
Diphenhydramine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.0013	0.00317	CcSEcCtD
Diphenhydramine—PTGS1—smooth muscle tissue—systemic scleroderma	0.0013	0.0189	CbGeAlD
Diphenhydramine—Confusional state—Mycophenolic acid—systemic scleroderma	0.0013	0.00315	CcSEcCtD
Diphenhydramine—Anorexia—Leflunomide—systemic scleroderma	0.00128	0.00313	CcSEcCtD
Diphenhydramine—PTGS1—skin of body—systemic scleroderma	0.00128	0.0187	CbGeAlD
Diphenhydramine—Nausea—Pentoxifylline—systemic scleroderma	0.00128	0.00312	CcSEcCtD
Diphenhydramine—Chills—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00312	CcSEcCtD
Diphenhydramine—Vertigo—Lisinopril—systemic scleroderma	0.00127	0.0031	CcSEcCtD
Diphenhydramine—Diarrhoea—Mometasone—systemic scleroderma	0.00127	0.0031	CcSEcCtD
Diphenhydramine—Hypotension—Leflunomide—systemic scleroderma	0.00126	0.00306	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00126	0.00306	CcSEcCtD
Diphenhydramine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00125	0.00305	CcSEcCtD
Diphenhydramine—Palpitations—Lisinopril—systemic scleroderma	0.00125	0.00305	CcSEcCtD
Diphenhydramine—SLC22A5—tendon—systemic scleroderma	0.00124	0.0181	CbGeAlD
Diphenhydramine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00124	0.00302	CcSEcCtD
Diphenhydramine—Anorexia—Mycophenolic acid—systemic scleroderma	0.00123	0.00298	CcSEcCtD
Diphenhydramine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00297	CcSEcCtD
Diphenhydramine—Insomnia—Leflunomide—systemic scleroderma	0.00122	0.00297	CcSEcCtD
Diphenhydramine—Paraesthesia—Leflunomide—systemic scleroderma	0.00121	0.00295	CcSEcCtD
Diphenhydramine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00294	CcSEcCtD
Diphenhydramine—Hypotension—Mycophenolic acid—systemic scleroderma	0.0012	0.00292	CcSEcCtD
Diphenhydramine—Dyspepsia—Leflunomide—systemic scleroderma	0.00119	0.00289	CcSEcCtD
Diphenhydramine—CYP1A2—digestive system—systemic scleroderma	0.00118	0.0173	CbGeAlD
Diphenhydramine—Vomiting—Mometasone—systemic scleroderma	0.00118	0.00288	CcSEcCtD
Diphenhydramine—Dry mouth—Lisinopril—systemic scleroderma	0.00118	0.00288	CcSEcCtD
Diphenhydramine—Sweating increased—Prednisone—systemic scleroderma	0.00118	0.00287	CcSEcCtD
Diphenhydramine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00118	0.00286	CcSEcCtD
Diphenhydramine—Rash—Mometasone—systemic scleroderma	0.00117	0.00286	CcSEcCtD
Diphenhydramine—Asthenia—Captopril—systemic scleroderma	0.00117	0.00286	CcSEcCtD
Diphenhydramine—Dermatitis—Mometasone—systemic scleroderma	0.00117	0.00285	CcSEcCtD
Diphenhydramine—Decreased appetite—Leflunomide—systemic scleroderma	0.00117	0.00285	CcSEcCtD
Diphenhydramine—Confusional state—Lisinopril—systemic scleroderma	0.00117	0.00284	CcSEcCtD
Diphenhydramine—Headache—Mometasone—systemic scleroderma	0.00117	0.00284	CcSEcCtD
Diphenhydramine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00283	CcSEcCtD
Diphenhydramine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00116	0.00283	CcSEcCtD
Diphenhydramine—Fatigue—Leflunomide—systemic scleroderma	0.00116	0.00283	CcSEcCtD
Diphenhydramine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00115	0.00281	CcSEcCtD
Diphenhydramine—Constipation—Leflunomide—systemic scleroderma	0.00115	0.0028	CcSEcCtD
Diphenhydramine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00114	0.00278	CcSEcCtD
Diphenhydramine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00278	CcSEcCtD
Diphenhydramine—CYP2B6—digestive system—systemic scleroderma	0.00114	0.0165	CbGeAlD
Diphenhydramine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00113	0.00276	CcSEcCtD
Diphenhydramine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00113	0.00275	CcSEcCtD
Diphenhydramine—Tachycardia—Lisinopril—systemic scleroderma	0.00113	0.00275	CcSEcCtD
Diphenhydramine—CYP2C9—digestive system—systemic scleroderma	0.00112	0.0164	CbGeAlD
Diphenhydramine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00112	0.00272	CcSEcCtD
Diphenhydramine—Diarrhoea—Captopril—systemic scleroderma	0.00112	0.00272	CcSEcCtD
Diphenhydramine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00112	0.00272	CcSEcCtD
Diphenhydramine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00272	CcSEcCtD
Diphenhydramine—Irritability—Methotrexate—systemic scleroderma	0.00112	0.00272	CcSEcCtD
Diphenhydramine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00111	0.0027	CcSEcCtD
Diphenhydramine—HRH1—digestive system—systemic scleroderma	0.00111	0.0162	CbGeAlD
Diphenhydramine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00111	0.0027	CcSEcCtD
Diphenhydramine—Nausea—Mometasone—systemic scleroderma	0.00111	0.00269	CcSEcCtD
Diphenhydramine—Anorexia—Lisinopril—systemic scleroderma	0.0011	0.00269	CcSEcCtD
Diphenhydramine—Constipation—Mycophenolic acid—systemic scleroderma	0.0011	0.00268	CcSEcCtD
Diphenhydramine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00267	CcSEcCtD
Diphenhydramine—SLC22A5—lung—systemic scleroderma	0.00109	0.0159	CbGeAlD
Diphenhydramine—Hypotension—Lisinopril—systemic scleroderma	0.00108	0.00263	CcSEcCtD
Diphenhydramine—Dizziness—Captopril—systemic scleroderma	0.00108	0.00263	CcSEcCtD
Diphenhydramine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00262	CcSEcCtD
Diphenhydramine—Urticaria—Leflunomide—systemic scleroderma	0.00107	0.00261	CcSEcCtD
Diphenhydramine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00106	0.00258	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00106	0.00257	CcSEcCtD
Diphenhydramine—HRH1—tendon—systemic scleroderma	0.00106	0.0154	CbGeAlD
Diphenhydramine—Insomnia—Lisinopril—systemic scleroderma	0.00105	0.00255	CcSEcCtD
Diphenhydramine—Paraesthesia—Lisinopril—systemic scleroderma	0.00104	0.00253	CcSEcCtD
Diphenhydramine—Vomiting—Captopril—systemic scleroderma	0.00104	0.00253	CcSEcCtD
Diphenhydramine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00252	CcSEcCtD
Diphenhydramine—Rash—Captopril—systemic scleroderma	0.00103	0.00251	CcSEcCtD
Diphenhydramine—Dermatitis—Captopril—systemic scleroderma	0.00103	0.00251	CcSEcCtD
Diphenhydramine—Somnolence—Lisinopril—systemic scleroderma	0.00103	0.00251	CcSEcCtD
Diphenhydramine—PTGS1—digestive system—systemic scleroderma	0.00103	0.015	CbGeAlD
Diphenhydramine—Headache—Captopril—systemic scleroderma	0.00102	0.00249	CcSEcCtD
Diphenhydramine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00249	CcSEcCtD
Diphenhydramine—Dyspepsia—Lisinopril—systemic scleroderma	0.00102	0.00248	CcSEcCtD
Diphenhydramine—Decreased appetite—Lisinopril—systemic scleroderma	0.00101	0.00245	CcSEcCtD
Diphenhydramine—Fatigue—Lisinopril—systemic scleroderma	0.000998	0.00243	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000993	0.00242	CcSEcCtD
Diphenhydramine—Constipation—Lisinopril—systemic scleroderma	0.00099	0.00241	CcSEcCtD
Diphenhydramine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00099	0.00241	CcSEcCtD
Diphenhydramine—CYP1A2—lung—systemic scleroderma	0.000989	0.0144	CbGeAlD
Diphenhydramine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000981	0.00239	CcSEcCtD
Diphenhydramine—PTGS1—tendon—systemic scleroderma	0.000977	0.0142	CbGeAlD
Diphenhydramine—Diarrhoea—Azathioprine—systemic scleroderma	0.000976	0.00238	CcSEcCtD
Diphenhydramine—Nausea—Captopril—systemic scleroderma	0.000971	0.00236	CcSEcCtD
Diphenhydramine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000967	0.00235	CcSEcCtD
Diphenhydramine—Asthenia—Leflunomide—systemic scleroderma	0.000967	0.00235	CcSEcCtD
Diphenhydramine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000954	0.00232	CcSEcCtD
Diphenhydramine—CYP2B6—lung—systemic scleroderma	0.000948	0.0138	CbGeAlD
Diphenhydramine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000948	0.00231	CcSEcCtD
Diphenhydramine—Dysuria—Methotrexate—systemic scleroderma	0.000945	0.0023	CcSEcCtD
Diphenhydramine—Dizziness—Azathioprine—systemic scleroderma	0.000944	0.0023	CcSEcCtD
Diphenhydramine—HRH1—lung—systemic scleroderma	0.000926	0.0135	CbGeAlD
Diphenhydramine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000923	0.00225	CcSEcCtD
Diphenhydramine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000922	0.00224	CcSEcCtD
Diphenhydramine—Diarrhoea—Leflunomide—systemic scleroderma	0.000922	0.00224	CcSEcCtD
Diphenhydramine—Urticaria—Lisinopril—systemic scleroderma	0.00092	0.00224	CcSEcCtD
Diphenhydramine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000918	0.00223	CcSEcCtD
Diphenhydramine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000911	0.00222	CcSEcCtD
Diphenhydramine—Vomiting—Azathioprine—systemic scleroderma	0.000907	0.00221	CcSEcCtD
Diphenhydramine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000902	0.0022	CcSEcCtD
Diphenhydramine—Drowsiness—Methotrexate—systemic scleroderma	0.000901	0.00219	CcSEcCtD
Diphenhydramine—Rash—Azathioprine—systemic scleroderma	0.0009	0.00219	CcSEcCtD
Diphenhydramine—Dermatitis—Azathioprine—systemic scleroderma	0.000899	0.00219	CcSEcCtD
Diphenhydramine—Headache—Azathioprine—systemic scleroderma	0.000894	0.00218	CcSEcCtD
Diphenhydramine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000893	0.00217	CcSEcCtD
Diphenhydramine—Dizziness—Leflunomide—systemic scleroderma	0.000891	0.00217	CcSEcCtD
Diphenhydramine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000882	0.00215	CcSEcCtD
Diphenhydramine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00088	0.00214	CcSEcCtD
Diphenhydramine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000868	0.00211	CcSEcCtD
Diphenhydramine—PTGS1—lung—systemic scleroderma	0.000857	0.0125	CbGeAlD
Diphenhydramine—Vomiting—Leflunomide—systemic scleroderma	0.000857	0.00209	CcSEcCtD
Diphenhydramine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00085	0.00207	CcSEcCtD
Diphenhydramine—Rash—Leflunomide—systemic scleroderma	0.00085	0.00207	CcSEcCtD
Diphenhydramine—Dermatitis—Leflunomide—systemic scleroderma	0.000849	0.00207	CcSEcCtD
Diphenhydramine—Nausea—Azathioprine—systemic scleroderma	0.000848	0.00206	CcSEcCtD
Diphenhydramine—Headache—Leflunomide—systemic scleroderma	0.000844	0.00205	CcSEcCtD
Diphenhydramine—CYP2D6—digestive system—systemic scleroderma	0.000844	0.0123	CbGeAlD
Diphenhydramine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000841	0.00205	CcSEcCtD
Diphenhydramine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000836	0.00203	CcSEcCtD
Diphenhydramine—Asthenia—Lisinopril—systemic scleroderma	0.000831	0.00202	CcSEcCtD
Diphenhydramine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000817	0.00199	CcSEcCtD
Diphenhydramine—Rash—Mycophenolic acid—systemic scleroderma	0.000811	0.00197	CcSEcCtD
Diphenhydramine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00081	0.00197	CcSEcCtD
Diphenhydramine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000806	0.00196	CcSEcCtD
Diphenhydramine—Headache—Mycophenolic acid—systemic scleroderma	0.000805	0.00196	CcSEcCtD
Diphenhydramine—Nausea—Leflunomide—systemic scleroderma	0.000801	0.00195	CcSEcCtD
Diphenhydramine—Vision blurred—Prednisone—systemic scleroderma	0.000794	0.00193	CcSEcCtD
Diphenhydramine—Diarrhoea—Lisinopril—systemic scleroderma	0.000792	0.00193	CcSEcCtD
Diphenhydramine—Agitation—Prednisone—systemic scleroderma	0.000774	0.00188	CcSEcCtD
Diphenhydramine—Dizziness—Lisinopril—systemic scleroderma	0.000766	0.00186	CcSEcCtD
Diphenhydramine—Nausea—Mycophenolic acid—systemic scleroderma	0.000764	0.00186	CcSEcCtD
Diphenhydramine—Vertigo—Prednisone—systemic scleroderma	0.000757	0.00184	CcSEcCtD
Diphenhydramine—Tinnitus—Methotrexate—systemic scleroderma	0.000754	0.00184	CcSEcCtD
Diphenhydramine—Vomiting—Lisinopril—systemic scleroderma	0.000736	0.00179	CcSEcCtD
Diphenhydramine—Rash—Lisinopril—systemic scleroderma	0.00073	0.00178	CcSEcCtD
Diphenhydramine—Convulsion—Prednisone—systemic scleroderma	0.00073	0.00178	CcSEcCtD
Diphenhydramine—Dermatitis—Lisinopril—systemic scleroderma	0.000729	0.00178	CcSEcCtD
Diphenhydramine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000728	0.00177	CcSEcCtD
Diphenhydramine—Chills—Methotrexate—systemic scleroderma	0.000726	0.00177	CcSEcCtD
Diphenhydramine—Headache—Lisinopril—systemic scleroderma	0.000725	0.00177	CcSEcCtD
Diphenhydramine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000694	0.00169	CcSEcCtD
Diphenhydramine—Nausea—Lisinopril—systemic scleroderma	0.000688	0.00167	CcSEcCtD
Diphenhydramine—Tachycardia—Prednisone—systemic scleroderma	0.000671	0.00163	CcSEcCtD
Diphenhydramine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000671	0.00163	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000665	0.00162	CcSEcCtD
Diphenhydramine—Vision blurred—Methotrexate—systemic scleroderma	0.000664	0.00162	CcSEcCtD
Diphenhydramine—Anorexia—Prednisone—systemic scleroderma	0.000656	0.0016	CcSEcCtD
Diphenhydramine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000645	0.00157	CcSEcCtD
Diphenhydramine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00064	0.00156	CcSEcCtD
Diphenhydramine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000639	0.00156	CcSEcCtD
Diphenhydramine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000636	0.00155	CcSEcCtD
Diphenhydramine—Vertigo—Methotrexate—systemic scleroderma	0.000633	0.00154	CcSEcCtD
Diphenhydramine—Insomnia—Prednisone—systemic scleroderma	0.000622	0.00151	CcSEcCtD
Diphenhydramine—Paraesthesia—Prednisone—systemic scleroderma	0.000618	0.0015	CcSEcCtD
Diphenhydramine—Convulsion—Methotrexate—systemic scleroderma	0.00061	0.00149	CcSEcCtD
Diphenhydramine—Dyspepsia—Prednisone—systemic scleroderma	0.000605	0.00147	CcSEcCtD
Diphenhydramine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000603	0.00147	CcSEcCtD
Diphenhydramine—Decreased appetite—Prednisone—systemic scleroderma	0.000598	0.00146	CcSEcCtD
Diphenhydramine—Fatigue—Prednisone—systemic scleroderma	0.000593	0.00144	CcSEcCtD
Diphenhydramine—Constipation—Prednisone—systemic scleroderma	0.000588	0.00143	CcSEcCtD
Diphenhydramine—Confusional state—Methotrexate—systemic scleroderma	0.00058	0.00141	CcSEcCtD
Diphenhydramine—Feeling abnormal—Prednisone—systemic scleroderma	0.000567	0.00138	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000563	0.00137	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000556	0.00135	CcSEcCtD
Diphenhydramine—Anorexia—Methotrexate—systemic scleroderma	0.000548	0.00133	CcSEcCtD
Diphenhydramine—Urticaria—Prednisone—systemic scleroderma	0.000546	0.00133	CcSEcCtD
Diphenhydramine—Hypotension—Methotrexate—systemic scleroderma	0.000537	0.00131	CcSEcCtD
Diphenhydramine—Insomnia—Methotrexate—systemic scleroderma	0.00052	0.00127	CcSEcCtD
Diphenhydramine—Paraesthesia—Methotrexate—systemic scleroderma	0.000516	0.00126	CcSEcCtD
Diphenhydramine—Somnolence—Methotrexate—systemic scleroderma	0.000511	0.00124	CcSEcCtD
Diphenhydramine—Dyspepsia—Methotrexate—systemic scleroderma	0.000506	0.00123	CcSEcCtD
Diphenhydramine—Decreased appetite—Methotrexate—systemic scleroderma	0.0005	0.00122	CcSEcCtD
Diphenhydramine—Fatigue—Methotrexate—systemic scleroderma	0.000496	0.00121	CcSEcCtD
Diphenhydramine—Asthenia—Prednisone—systemic scleroderma	0.000493	0.0012	CcSEcCtD
Diphenhydramine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000474	0.00115	CcSEcCtD
Diphenhydramine—Diarrhoea—Prednisone—systemic scleroderma	0.000471	0.00115	CcSEcCtD
Diphenhydramine—Urticaria—Methotrexate—systemic scleroderma	0.000457	0.00111	CcSEcCtD
Diphenhydramine—Dizziness—Prednisone—systemic scleroderma	0.000455	0.00111	CcSEcCtD
Diphenhydramine—Vomiting—Prednisone—systemic scleroderma	0.000437	0.00106	CcSEcCtD
Diphenhydramine—Rash—Prednisone—systemic scleroderma	0.000434	0.00106	CcSEcCtD
Diphenhydramine—Dermatitis—Prednisone—systemic scleroderma	0.000433	0.00105	CcSEcCtD
Diphenhydramine—Headache—Prednisone—systemic scleroderma	0.000431	0.00105	CcSEcCtD
Diphenhydramine—Asthenia—Methotrexate—systemic scleroderma	0.000412	0.001	CcSEcCtD
Diphenhydramine—Nausea—Prednisone—systemic scleroderma	0.000409	0.000994	CcSEcCtD
Diphenhydramine—Diarrhoea—Methotrexate—systemic scleroderma	0.000393	0.000957	CcSEcCtD
Diphenhydramine—Dizziness—Methotrexate—systemic scleroderma	0.00038	0.000925	CcSEcCtD
Diphenhydramine—Vomiting—Methotrexate—systemic scleroderma	0.000365	0.000889	CcSEcCtD
Diphenhydramine—Rash—Methotrexate—systemic scleroderma	0.000362	0.000882	CcSEcCtD
Diphenhydramine—Dermatitis—Methotrexate—systemic scleroderma	0.000362	0.000881	CcSEcCtD
Diphenhydramine—Headache—Methotrexate—systemic scleroderma	0.00036	0.000876	CcSEcCtD
Diphenhydramine—Nausea—Methotrexate—systemic scleroderma	0.000341	0.000831	CcSEcCtD
